NV-5138 a novel, direct activator of the mechanistic target of rapamycin complex 1 (mTORC1): A phase 1b randomized, double-blind, placebo-controlled single oral dose study in subjects with treatment-resistant depression (TRD)

Authors
Category Primary study
ConferenceNeuropsychopharmacology
Year 2019
This article has no abstract
Epistemonikos ID: 2abb24e5f65c59c6b98cb3049fa133cf16d5f62e
First added on: Apr 29, 2026